{"altmetric_id":24456548,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":46},"news":{"unique_users_count":2,"unique_users":["oncology_nurse_advisor","the_asco_post"],"posts_count":2},"twitter":{"unique_users_count":37,"unique_users":["FarmaOnco","wlsaber","HayderSaeed_MD","khaledghanem","satya_yadav","BldCancerDoc","DrMiguelPerales","dgermain21","CIBMTR","drjgauthier","Nadim_M_Chicago","morenodegusmao","DrAmitPatel","DamianoRondell1","hematosantpau","DrRaulCordoba","nadiradu","VIPOnHematology","cryostem_FR","TeresaKing65","drdeepakg","alex_akanell","AronFlaggMD","Earthangelfl","albertomussetti","SaudiLeukemia","BowTiedPharmer","hipokrat74","JCO_ASCO","VCCLibrary","jvalentingg","Colombianne","josonc10","hidrhere","frickjifang","EBMT2017","jlll_hem"],"posts_count":44}},"selected_quotes":["PT Cy-Haploidentical HCT vs. ident sib donor HCT or Unrelated Donor HCT for Hodgkin Lymphoma","Post-transplant cyclophosphamide-based haploidentical alloHCT for Hodgkin lymphoma #lymsm","Haplo-transplant increases pt access lowers costs in LMIC hosp w good quality standards #GlobalB @Poudya\u2026","Haploidentical Transplantation as Alternative to Matched Sibling MUD for HD:JCO","Haplo #bmtsm seem to have best of both worlds! Less chronic #gvhd and more disease ctrl #lymsm @JCO_ASCO @TheEBMT"],"citation":{"abstract":"Purpose To compare the outcome of patients with Hodgkin lymphoma who received post-transplantation cyclophosphamide-based haploidentical (HAPLO) allogeneic hematopoietic cell transplantation with the outcome of patients who received conventional HLA-matched sibling donor (SIB) and HLA-matched unrelated donor (MUD). Patients and Methods We retrospectively evaluated 709 adult patients with Hodgkin lymphoma who were registered in the European Society for Blood and Marrow Transplantation database who received HAPLO (n = 98), SIB (n = 338), or MUD (n = 273) transplantation. Results Median follow-up of survivors was 29 months. No differences were observed between groups in the incidence of acute graft-versus-host disease (GVHD). HAPLO was associated with a lower risk of chronic GVHD (26%) compared with MUD (41%; P = .04). Cumulative incidence of nonrelapse mortality at 1 year was 17%, 13%, and 21% in HAPLO, SIB, and MUD, respectively, and corresponding 2-year cumulative incidence of relapse or progression was 39%, 49%, and 32%, respectively. On multivariable analysis, relative to SIB, nonrelapse mortality was similar in HAPLO ( P = .26) and higher in MUD ( P = .003), and risk of relapse was lower in both HAPLO ( P = .047) and MUD ( P < .001). Two-year overall survival and progression-free survival were 67% and 43% for HAPLO, 71% and 38% for SIB, and 62% and 45% for MUD, respectively. There were no significant differences in overall survival or progression-free survival between HAPLO and SIB or MUD. The rate of the composite end point of extensive chronic GVHD and relapse-free survival was significantly better for HAPLO (40%) compared with SIB (28%; P = .049) and similar to MUD (38%; P = .59). Conclusion Post-transplantation cyclophosphamide-based HAPLO transplantation results in similar survival outcomes compared with SIB and MUD, which confirms its suitability when no conventional donor is available. Our results also suggest that HAPLO results in a lower risk of chronic GVHD than MUD transplantation.","altmetric_jid":"4f6fa5e93cf058f610005a18","authors":["Carmen Mart\u00ednez","Jorge Gayoso","Carmen Canals","Herv\u00e9 Finel","Karl Peggs","Alida Dominietto","Luca Castagna","Boris Afanasyev","Stephen Robinson","Didier Blaise","Paolo Corradini","Maija It\u00e4l\u00e4-Remes","Arancha Berm\u00fadez","Edouard Forcade","Domenico Russo","Michael Potter","Grant McQuaker","Ibrahim Yakoub-Agha","Christof Scheid","Adrian Bloor","Silvia Montoto","Peter Dreger","Anna Sureda","on behalf of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation"],"doi":"10.1200\/jco.2017.72.6869","first_seen_on":"2017-08-29T04:23:19+00:00","funders":["niehs"],"handles":[],"issns":["0732-183X","1527-7755"],"journal":"Journal of Clinical Oncology","last_mentioned_on":1506319573,"links":["http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.72.6869?af=R","http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.72.6869","http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.72.6869#.WaVVzMobakI.twitter","http:\/\/ascopubs.org\/doi\/pdf\/10.1200\/JCO.2017.72.6869","http:\/\/dx.doi.org\/10.1200\/JCO.2017.72.6869","http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2017.72.6869#.WcfbMCOciZQ.twitter"],"pmid":"28846465","pubdate":"2017-08-28T00:00:00+00:00","publisher":"American Society of Clinical Oncology","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/posttransplantation-cyclophosphamidebased-haploidentical-transplantation-alternative-matched-sibling"},"altmetric_score":{"score":38.85,"score_history":{"1y":38.85,"6m":38.85,"3m":38.85,"1m":17.4,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":38.85},"context_for_score":{"all":{"total_number_of_other_articles":8461697,"mean":7.1088157534769,"rank":243880,"this_scored_higher_than_pct":97,"this_scored_higher_than":8217864,"rank_type":"exact","sample_size":8461697,"percentile":97},"similar_age_3m":{"total_number_of_other_articles":180155,"mean":12.473584899586,"rank":10589,"this_scored_higher_than_pct":94,"this_scored_higher_than":169559,"rank_type":"exact","sample_size":180155,"percentile":94},"this_journal":{"total_number_of_other_articles":8977,"mean":15.377997103387,"rank":756,"this_scored_higher_than_pct":91,"this_scored_higher_than":8221,"rank_type":"exact","sample_size":8977,"percentile":91},"similar_age_this_journal_3m":{"total_number_of_other_articles":94,"mean":78.897806451613,"rank":39,"this_scored_higher_than_pct":58,"this_scored_higher_than":55,"rank_type":"exact","sample_size":94,"percentile":58}}},"demographics":{"poster_types":{"member_of_the_public":23,"researcher":4,"practitioner":9,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":23,"Practitioners (doctors, other healthcare professionals)":9,"Scientists":4,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Researcher":1,"Other":3},"by_discipline":{"Medicine and Dentistry":2,"Unspecified":2}}},"geo":{"twitter":{"US":12,"LB":1,"IN":3,"FR":3,"GB":4,"ES":4,"SA":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/FarmaOnco\/statuses\/902386101448564736","license":"gnip","citation_ids":[24456548],"posted_on":"2017-08-29T04:23:06+00:00","author":{"name":"FarmaOnco","image":"https:\/\/pbs.twimg.com\/profile_images\/2930931336\/c5ed1efcf9ddf36d4803c1ab88604f4f_normal.jpeg","description":"Farmac\u00e9utica hospitalaria que intenta mantenerse al d\u00eda en onco, hemato y otras cosas","id_on_source":"FarmaOnco","tweeter_id":"917639060","geo":{"lt":null,"ln":null},"followers":1686},"tweet_id":"902386101448564736"},{"url":"http:\/\/twitter.com\/wlsaber\/statuses\/902494489562017792","license":"gnip","citation_ids":[24456548],"posted_on":"2017-08-29T11:33:48+00:00","author":{"name":"Wael Saber","image":"https:\/\/pbs.twimg.com\/profile_images\/934193284\/pic_normal.JPG","id_on_source":"wlsaber","tweeter_id":"33256294","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":321},"tweet_id":"902494489562017792"},{"url":"http:\/\/twitter.com\/HayderSaeed_MD\/statuses\/902501233285627906","license":"gnip","citation_ids":[24456548],"posted_on":"2017-08-29T12:00:36+00:00","author":{"name":"Hayder Saeed, MD","url":"http:\/\/haydersaeedmd.com","image":"https:\/\/pbs.twimg.com\/profile_images\/886410120153976832\/X_GcSA0h_normal.jpg","description":"A hematology and BMT doctor @UKMarkey . Tweets are not endorsements, and not medical advice.","id_on_source":"HayderSaeed_MD","tweeter_id":"2745965651","geo":{"lt":37.98869,"ln":-84.47772,"country":"US"},"followers":240},"tweet_id":"902501233285627906"},{"url":"http:\/\/twitter.com\/khaledghanem\/statuses\/902512392009121793","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-29T12:44:56+00:00","author":{"name":"Khaled Ghanem","url":"http:\/\/www.khaledghanem.com","image":"https:\/\/pbs.twimg.com\/profile_images\/779643915360165888\/OI60duW3_normal.jpg","description":"Pediatric Hematology Oncology Research Fellow at the American University of Beirut","id_on_source":"khaledghanem","tweeter_id":"38667349","geo":{"lt":33.83333,"ln":35.83333,"country":"LB"},"followers":515},"tweet_id":"902512392009121793"},{"url":"http:\/\/twitter.com\/satya_yadav\/statuses\/902525615802220546","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-29T13:37:29+00:00","author":{"name":"Satya Prakash Yadav","url":"https:\/\/scholar.google.co.in\/citations?user=ZBx2DK4AAAAJ&hl=en","image":"https:\/\/pbs.twimg.com\/profile_images\/821028432645484544\/8eqw00l2_normal.jpg","description":"Director, Pediatric Hematology Oncology & Bone Marrow Transplant, Medanta Hospital, Gurgaon, Haryana, India","id_on_source":"satya_yadav","tweeter_id":"113879784","geo":{"lt":28.4601,"ln":77.02635,"country":"IN"},"followers":860},"tweet_id":"902525615802220546"},{"url":"http:\/\/twitter.com\/BldCancerDoc\/statuses\/902527185503780865","license":"gnip","rt":["HayderSaeed_MD"],"citation_ids":[24456548],"posted_on":"2017-08-29T13:43:43+00:00","author":{"name":"Navneet Majhail, MD","url":"http:\/\/clevelandclinic.org\/bmt","image":"https:\/\/pbs.twimg.com\/profile_images\/518962445641986048\/xWAmho1l_normal.jpeg","description":"Director, Blood & Marrow Transplant Program, @ClevelandClinic | Vice President @ASBMT | Blood cancers, BMT, health policy, musings as doc | Opinions my own","id_on_source":"BldCancerDoc","tweeter_id":"2809497047","geo":{"lt":41.4995,"ln":-81.69541,"country":"US"},"followers":4803},"tweet_id":"902527185503780865"},{"url":"http:\/\/twitter.com\/satya_yadav\/statuses\/902547356364582913","license":"gnip","rt":["HayderSaeed_MD"],"citation_ids":[24456548],"posted_on":"2017-08-29T15:03:52+00:00","author":{"name":"Satya Prakash Yadav","url":"https:\/\/scholar.google.co.in\/citations?user=ZBx2DK4AAAAJ&hl=en","image":"https:\/\/pbs.twimg.com\/profile_images\/821028432645484544\/8eqw00l2_normal.jpg","description":"Director, Pediatric Hematology Oncology & Bone Marrow Transplant, Medanta Hospital, Gurgaon, Haryana, India","id_on_source":"satya_yadav","tweeter_id":"113879784","geo":{"lt":28.4601,"ln":77.02635,"country":"IN"},"followers":860},"tweet_id":"902547356364582913"},{"url":"http:\/\/twitter.com\/DrMiguelPerales\/statuses\/902566403940552704","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-29T16:19:34+00:00","author":{"name":"Miguel Perales M.D.","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/miguel-angel-perales","image":"https:\/\/pbs.twimg.com\/profile_images\/420287281832787968\/QqvGIWhX_normal.jpeg","description":"Oncologist @sloan_kettering. Stem cell transplantation Lymphoma Leukemia MDS Myeloma Immunotherapy Vaccines. @BeTheMatch & @ASBMT Board Member. Tweets mine.","id_on_source":"DrMiguelPerales","tweeter_id":"1407780158","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":6676},"tweet_id":"902566403940552704"},{"url":"http:\/\/twitter.com\/dgermain21\/statuses\/902579977182482432","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-29T17:13:30+00:00","author":{"name":"D. Russler-Germain","image":"https:\/\/pbs.twimg.com\/profile_images\/724019223127678978\/K5RNn4Of_normal.jpg","description":"MD-PhD. Hematology\/oncology physician-scientist-in-training. Tweet\/RT not medical advice or endorsement.","id_on_source":"dgermain21","tweeter_id":"18821994","geo":{"lt":38.62727,"ln":-90.19789,"country":"US"},"followers":982},"tweet_id":"902579977182482432"},{"url":"http:\/\/twitter.com\/CIBMTR\/statuses\/902634066868133888","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-29T20:48:26+00:00","author":{"name":"CIBMTR","url":"http:\/\/www.cibmtr.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/449599390663991297\/jvk6iTvy_normal.png","description":"Research organization, collaborating with the global scientific community in an effort to increase survival and enrich quality of life for patients needing BMT.","id_on_source":"CIBMTR","tweeter_id":"409520224","geo":{"lt":43.04946,"ln":-88.00759,"country":"US"},"followers":1542},"tweet_id":"902634066868133888"},{"url":"http:\/\/twitter.com\/drjgauthier\/statuses\/902642898503581696","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-29T21:23:31+00:00","author":{"name":"Jordan Gauthier","image":"https:\/\/pbs.twimg.com\/profile_images\/735051953168908288\/5zyWDI3__normal.jpg","description":"MD, MSc, Sr Fellow @fredhutch #tcellrx focused on adoptive T-cell therapy, #immunotherapy #immunoOnc","id_on_source":"drjgauthier","tweeter_id":"4466075238","geo":{"lt":50.63297,"ln":3.05858,"country":"FR"},"followers":667},"tweet_id":"902642898503581696"},{"url":"http:\/\/twitter.com\/Nadim_M_Chicago\/statuses\/902666781764063233","license":"gnip","rt":["HayderSaeed_MD"],"citation_ids":[24456548],"posted_on":"2017-08-29T22:58:26+00:00","author":{"name":"Dr. Nadim Mahmud","image":"https:\/\/pbs.twimg.com\/profile_images\/833918672641077249\/8jbpNtSk_normal.jpg","description":"Associate Professor of Medicine, Hematology\/Oncology, Blood & Marrow Transplantation, Director, Clinical Stem Cell Laboratory; UI Health, Tweets are personal","id_on_source":"Nadim_M_Chicago","tweeter_id":"797667657340354560","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":212},"tweet_id":"902666781764063233"},{"url":"http:\/\/twitter.com\/morenodegusmao\/statuses\/902704310768861184","license":"gnip","citation_ids":[24456548],"posted_on":"2017-08-30T01:27:33+00:00","author":{"name":"BrenoMorenodeGusm\u00e3o","image":"https:\/\/pbs.twimg.com\/profile_images\/899268059050987523\/Vw4IvzOJ_normal.jpg","description":"Hematologist at Hospital Israelita Albert Einstein and Benefic\u00eancia Portuguesa de S\u00e3o Paulo","id_on_source":"morenodegusmao","tweeter_id":"1276027482","geo":{"lt":null,"ln":null},"followers":52},"tweet_id":"902704310768861184"},{"url":"http:\/\/twitter.com\/DrAmitPatel\/statuses\/902710947063754753","license":"gnip","citation_ids":[24456548],"posted_on":"2017-08-30T01:53:55+00:00","author":{"name":"Amit Patel","url":"https:\/\/www.liverpool.ac.uk\/translational-medicine\/staff\/amit-patel\/","image":"https:\/\/pbs.twimg.com\/profile_images\/773319906649579520\/TXnfaHZF_normal.jpg","description":"Consultant & Senior Lecturer: Stem Cell Transplantation & Intensive Care Medicine @CCCNHS @LivUni. Own views: cellular immunotherapy, leukaemia, sepsis, GvHD","id_on_source":"DrAmitPatel","tweeter_id":"187655113","geo":{"lt":53.41058,"ln":-2.97794,"country":"GB"},"followers":216},"tweet_id":"902710947063754753"},{"url":"http:\/\/twitter.com\/DamianoRondell1\/statuses\/902733303010250752","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-30T03:22:46+00:00","author":{"name":"Damiano Rondelli","image":"https:\/\/pbs.twimg.com\/profile_images\/721105670574063616\/IOeTc_br_normal.jpg","description":"Michael Reese Professor of Hematology, Chief Hematology\/Oncology -Director BMT- Univ of Illinois Chicago @UICDom @UILCancerCtr @UIC_CGH","id_on_source":"DamianoRondell1","tweeter_id":"721090754064609280","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":439},"tweet_id":"902733303010250752"},{"url":"http:\/\/twitter.com\/hematosantpau\/statuses\/902747162576134144","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-30T04:17:50+00:00","author":{"name":"Hematolog\u00eda SantPau","url":"http:\/\/www.santpau.cat\/ca\/web\/public\/hc-inici","image":"https:\/\/pbs.twimg.com\/profile_images\/753318144626847745\/oK2mXlI4_normal.jpg","description":"Hospital de la Santa Creu i Sant Pau","id_on_source":"hematosantpau","tweeter_id":"721616184731426816","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":376},"tweet_id":"902747162576134144"},{"url":"http:\/\/twitter.com\/DrRaulCordoba\/statuses\/902765613780799489","license":"gnip","citation_ids":[24456548],"posted_on":"2017-08-30T05:31:09+00:00","author":{"name":"Raul Cordoba","url":"http:\/\/www.fjd.es","image":"https:\/\/pbs.twimg.com\/profile_images\/817087500850229248\/LRpwr7_9_normal.jpg","description":"\ud83c\uddea\ud83c\uddf8Mi Vocaci\u00f3n? La Medicina. Mi Pasi\u00f3n? La Hematolog\u00eda. Mi especialidad? Los Linfomas \ud83c\uddfa\ud83c\uddf8Doctor. Hematologist. Interest in #lymphoma #CLL #gerionc #ImmunoOnc","id_on_source":"DrRaulCordoba","tweeter_id":"1697360292","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":2032},"tweet_id":"902765613780799489"},{"url":"http:\/\/twitter.com\/nadiradu\/statuses\/902774333944320000","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-30T06:05:48+00:00","author":{"name":"Nadira Durakovi\u0107","image":"https:\/\/pbs.twimg.com\/profile_images\/802620434625822720\/_TvDWjgP_normal.jpg","description":"Volim misliti da mijenjam svijet na bolje, dan po dan.","id_on_source":"nadiradu","tweeter_id":"802616635962126336","geo":{"lt":null,"ln":null},"followers":28},"tweet_id":"902774333944320000"},{"url":"http:\/\/twitter.com\/VIPOnHematology\/statuses\/902776044859613184","license":"gnip","rt":["DrRaulCordoba"],"citation_ids":[24456548],"posted_on":"2017-08-30T06:12:36+00:00","author":{"name":"VIP_oncohematology","url":"http:\/\/www.oncohematology.it\/","image":"https:\/\/pbs.twimg.com\/profile_images\/819938145898811392\/pP7cebaO_normal.jpg","description":"Insights and updates on Multiple #Myeloma and CD30+ #Lymphoma.","id_on_source":"VIPOnHematology","tweeter_id":"774233683880443904","geo":{"lt":null,"ln":null},"followers":121},"tweet_id":"902776044859613184"},{"url":"http:\/\/twitter.com\/cryostem_FR\/statuses\/902794576666259456","license":"gnip","citation_ids":[24456548],"posted_on":"2017-08-30T07:26:14+00:00","author":{"name":"Cryostem","url":"http:\/\/cryostem.org","image":"https:\/\/pbs.twimg.com\/profile_images\/902799626352386049\/nQoxQBD1_normal.jpg","description":"National cohort over 170 000 samples from 4,500 patients pre- & post- #allogeneic #hematopoieticstemcell transplantation #HSCT to fight complications #bmtsm","id_on_source":"cryostem_FR","tweeter_id":"819111343320158208","geo":{"lt":46,"ln":2,"country":"FR"},"followers":107},"tweet_id":"902794576666259456"},{"url":"http:\/\/twitter.com\/TeresaKing65\/statuses\/902799468696932352","license":"gnip","rt":["DrAmitPatel"],"citation_ids":[24456548],"posted_on":"2017-08-30T07:45:41+00:00","author":{"name":"Teresa King","image":"https:\/\/pbs.twimg.com\/profile_images\/782552282135142400\/aX-LcwTa_normal.jpg","id_on_source":"TeresaKing65","tweeter_id":"158452047","geo":{"lt":52.13459,"ln":-0.46632,"country":"GB"},"followers":25},"tweet_id":"902799468696932352"},{"url":"http:\/\/twitter.com\/drdeepakg\/statuses\/902850275488129026","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-30T11:07:34+00:00","author":{"name":"Dr Deepak Gupta","url":"http:\/\/www.cancerconsultjaipur.com","image":"https:\/\/pbs.twimg.com\/profile_images\/872796636761608192\/EIh5hR4t_normal.jpg","description":"Senior consultant n Bone Marrow transplant Physcian","id_on_source":"drdeepakg","tweeter_id":"1975374326","geo":{"lt":26.91962,"ln":75.78781,"country":"IN"},"followers":297},"tweet_id":"902850275488129026"},{"url":"http:\/\/twitter.com\/alex_akanell\/statuses\/902882254015299585","license":"gnip","citation_ids":[24456548],"posted_on":"2017-08-30T13:14:38+00:00","author":{"name":"Alex Kanellopoulos","image":"https:\/\/pbs.twimg.com\/profile_images\/803294507043323906\/Mv7GFoxq_normal.jpg","description":"Consultant Haematologist, NHS","id_on_source":"alex_akanell","tweeter_id":"580285635","geo":{"lt":52.48142,"ln":-1.89983,"country":"GB"},"followers":177},"tweet_id":"902882254015299585"},{"url":"http:\/\/twitter.com\/AronFlaggMD\/statuses\/902925212051759104","license":"gnip","citation_ids":[24456548],"posted_on":"2017-08-30T16:05:20+00:00","author":{"name":"Aron Flagg, MD","image":"https:\/\/pbs.twimg.com\/profile_images\/735837421561118720\/IQAv9vpe_normal.jpg","description":"Pediatric Hematologist\/Oncologist","id_on_source":"AronFlaggMD","tweeter_id":"4839096353","geo":{"lt":41.4995,"ln":-81.69541,"country":"US"},"followers":102},"tweet_id":"902925212051759104"},{"url":"http:\/\/twitter.com\/Earthangelfl\/statuses\/903027909799157760","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-30T22:53:25+00:00","author":{"name":"William A. Greene","image":"https:\/\/pbs.twimg.com\/profile_images\/759573358228807680\/KeB-tvGY_normal.jpg","description":"38 year old easy going guy from Detroit. Proud member of First Christian Church of Wilton Manors. I love Jesus, my family, and friends with all my heart.","id_on_source":"Earthangelfl","tweeter_id":"1686978289","geo":{"lt":26.16036,"ln":-80.13893,"country":"US"},"followers":2561},"tweet_id":"903027909799157760"},{"url":"http:\/\/twitter.com\/albertomussetti\/statuses\/903152583971364865","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-08-31T07:08:50+00:00","author":{"name":"Alberto Mussetti","image":"https:\/\/pbs.twimg.com\/profile_images\/516203456797745152\/-P6YuY_W_normal.jpeg","description":"Hematologist from Milan - Science & Health News #hematology #transplant #lymphoma #myeloma #leukemia","id_on_source":"albertomussetti","tweeter_id":"1018120008","geo":{"lt":null,"ln":null},"followers":251},"tweet_id":"903152583971364865"},{"url":"http:\/\/twitter.com\/SaudiLeukemia\/statuses\/903543486389071872","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-09-01T09:02:08+00:00","author":{"name":"Saudi Leukemia Net","url":"http:\/\/www.saudileukemia.org","image":"https:\/\/pbs.twimg.com\/profile_images\/678811169671507969\/h6ewOJc0_normal.jpg","description":"\u0627\u0644\u0634\u0628\u0643\u0629 \u0627\u0644\u0633\u0639\u0648\u062f\u064a\u0629 \u0644\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062f\u0645","id_on_source":"SaudiLeukemia","tweeter_id":"4462240413","geo":{"lt":24.68773,"ln":46.72185,"country":"SA"},"followers":687},"tweet_id":"903543486389071872"},{"url":"http:\/\/twitter.com\/BldCancerDoc\/statuses\/903589648303357952","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-09-01T12:05:34+00:00","author":{"name":"Navneet Majhail, MD","url":"http:\/\/clevelandclinic.org\/bmt","image":"https:\/\/pbs.twimg.com\/profile_images\/518962445641986048\/xWAmho1l_normal.jpeg","description":"Director, Blood & Marrow Transplant Program, @ClevelandClinic | Vice President @ASBMT | Blood cancers, BMT, health policy, musings as doc | Opinions my own","id_on_source":"BldCancerDoc","tweeter_id":"2809497047","geo":{"lt":41.4995,"ln":-81.69541,"country":"US"},"followers":4803},"tweet_id":"903589648303357952"},{"url":"http:\/\/twitter.com\/BowTiedPharmer\/statuses\/903594188285104128","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-09-01T12:23:37+00:00","author":{"name":"Jordan Miller","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000023087879\/2d49b4ef1dd34cf96612fe9e6647b90e_normal.jpeg","description":"Hem\/Onc pharmacy resident in Chapel Hill by way of OR, SC, and Utah. Love Utes, A's, Apple, Android, photography, pens, and most of all @heykayjen","id_on_source":"BowTiedPharmer","tweeter_id":"105241185","geo":{"lt":35.9132,"ln":-79.05584,"country":"US"},"followers":157},"tweet_id":"903594188285104128"},{"url":"http:\/\/twitter.com\/hipokrat74\/statuses\/903601130130862080","license":"gnip","rt":["wlsaber"],"citation_ids":[24456548],"posted_on":"2017-09-01T12:51:12+00:00","author":{"name":"g\u00fcltekin pekcan","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"hipokrat74","tweeter_id":"122640356","geo":{"lt":null,"ln":null},"followers":9},"tweet_id":"903601130130862080"},{"url":"http:\/\/twitter.com\/JCO_ASCO\/statuses\/905475862056894465","license":"gnip","citation_ids":[24456548],"posted_on":"2017-09-06T17:00:43+00:00","author":{"name":"J Clinical Oncology","url":"http:\/\/JCO.org","image":"https:\/\/pbs.twimg.com\/profile_images\/715981880357683201\/8GMeAgKJ_normal.jpg","description":"Journal of Clinical Oncology is the authoritative resource for significant oncology research, published 3 times per month by @ASCO.","id_on_source":"JCO_ASCO","tweeter_id":"2395900849","geo":{"lt":null,"ln":null},"followers":6978},"tweet_id":"905475862056894465"},{"url":"http:\/\/twitter.com\/VCCLibrary\/statuses\/905537709091020801","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[24456548],"posted_on":"2017-09-06T21:06:28+00:00","author":{"name":"Cancer Library VCC","url":"http:\/\/www.wales.nhs.uk\/velindrelibrary","image":"https:\/\/pbs.twimg.com\/profile_images\/478464349476884480\/YlBsicot_normal.jpeg","description":"The only cancer specialist library service in Wales.  Supporting NHS and academic staff, students and health professionals throughout the Principality.","id_on_source":"VCCLibrary","tweeter_id":"1288296943","geo":{"lt":51.48,"ln":-3.18,"country":"GB"},"followers":657},"tweet_id":"905537709091020801"},{"url":"http:\/\/twitter.com\/jvalentingg\/statuses\/905664054525444102","license":"gnip","citation_ids":[24456548],"posted_on":"2017-09-07T05:28:31+00:00","author":{"name":"Valentin Garcia","image":"https:\/\/pbs.twimg.com\/profile_images\/684838077047685121\/dHXOajdv_normal.jpg","description":"Hematologo en Hospital Universitario Ramon y Cajal (Madrid, Spain). Profesor asociado Universidad de Alcal\u00e1. Granaino, marido y padre en Madrid","id_on_source":"jvalentingg","tweeter_id":"2904855645","geo":{"lt":null,"ln":null},"followers":120},"tweet_id":"905664054525444102"},{"url":"http:\/\/twitter.com\/VIPOnHematology\/statuses\/905679982638325760","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[24456548],"posted_on":"2017-09-07T06:31:49+00:00","author":{"name":"VIP_oncohematology","url":"http:\/\/www.oncohematology.it\/","image":"https:\/\/pbs.twimg.com\/profile_images\/819938145898811392\/pP7cebaO_normal.jpg","description":"Insights and updates on Multiple #Myeloma and CD30+ #Lymphoma.","id_on_source":"VIPOnHematology","tweeter_id":"774233683880443904","geo":{"lt":null,"ln":null},"followers":121},"tweet_id":"905679982638325760"},{"url":"http:\/\/twitter.com\/Colombianne\/statuses\/905707814567501824","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[24456548],"posted_on":"2017-09-07T08:22:24+00:00","author":{"name":"AmRoca","image":"https:\/\/pbs.twimg.com\/profile_images\/888822359741911040\/Jfwj7h4g_normal.jpg","description":"4th year hematology fellow at Hospital Universitari Joan XXXIII. #hematology #hemepath #HSCT\n\n\n\ud83d\udcabI'm easily distracted by shiny objects.. \ud83d\udcab","id_on_source":"Colombianne","tweeter_id":"20908266","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":283},"tweet_id":"905707814567501824"},{"url":"http:\/\/twitter.com\/josonc10\/statuses\/905713206722797568","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[24456548],"posted_on":"2017-09-07T08:43:50+00:00","author":{"name":"Jose Castillo","image":"https:\/\/pbs.twimg.com\/profile_images\/1558130315\/Devil_vs_Jesus_by_ongchewpeng_normal.jpg","id_on_source":"josonc10","tweeter_id":"343744269","geo":{"lt":null,"ln":null},"followers":35},"tweet_id":"905713206722797568"},{"url":"http:\/\/twitter.com\/hidrhere\/statuses\/911989078635069445","license":"gnip","citation_ids":[24456548],"posted_on":"2017-09-24T16:21:54+00:00","author":{"name":"Dr.Santhosh kumar","image":"https:\/\/pbs.twimg.com\/profile_images\/785832781897019392\/RbzbW8UJ_normal.jpg","description":"Oncologist\/Hematologist, Avid reader, Swayamsevak","id_on_source":"hidrhere","tweeter_id":"54969547","geo":{"lt":20,"ln":77,"country":"IN"},"followers":347},"tweet_id":"911989078635069445"},{"url":"http:\/\/twitter.com\/DamianoRondell1\/statuses\/911994167039070208","license":"gnip","rt":["hidrhere"],"citation_ids":[24456548],"posted_on":"2017-09-24T16:42:08+00:00","author":{"name":"Damiano Rondelli","image":"https:\/\/pbs.twimg.com\/profile_images\/721105670574063616\/IOeTc_br_normal.jpg","description":"Michael Reese Professor of Hematology, Chief Hematology\/Oncology -Director BMT- Univ of Illinois Chicago @UICDom @UILCancerCtr @UIC_CGH","id_on_source":"DamianoRondell1","tweeter_id":"721090754064609280","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":439},"tweet_id":"911994167039070208"},{"url":"http:\/\/twitter.com\/DamianoRondell1\/statuses\/911995687126040576","license":"gnip","citation_ids":[24456548],"posted_on":"2017-09-24T16:48:10+00:00","author":{"name":"Damiano Rondelli","image":"https:\/\/pbs.twimg.com\/profile_images\/721105670574063616\/IOeTc_br_normal.jpg","description":"Michael Reese Professor of Hematology, Chief Hematology\/Oncology -Director BMT- Univ of Illinois Chicago @UICDom @UILCancerCtr @UIC_CGH","id_on_source":"DamianoRondell1","tweeter_id":"721090754064609280","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":439},"tweet_id":"911995687126040576"},{"url":"http:\/\/twitter.com\/BldCancerDoc\/statuses\/912013017772183552","license":"gnip","rt":["DamianoRondell1"],"citation_ids":[24456548],"posted_on":"2017-09-24T17:57:02+00:00","author":{"name":"Navneet Majhail, MD","url":"http:\/\/clevelandclinic.org\/bmt","image":"https:\/\/pbs.twimg.com\/profile_images\/518962445641986048\/xWAmho1l_normal.jpeg","description":"Director, Blood & Marrow Transplant Program, @ClevelandClinic | Vice President @ASBMT | Blood cancers, BMT, health policy, musings as doc | Opinions my own","id_on_source":"BldCancerDoc","tweeter_id":"2809497047","geo":{"lt":41.4995,"ln":-81.69541,"country":"US"},"followers":4803},"tweet_id":"912013017772183552"},{"url":"http:\/\/twitter.com\/DrMiguelPerales\/statuses\/912058432018108417","license":"gnip","rt":["DamianoRondell1"],"citation_ids":[24456548],"posted_on":"2017-09-24T20:57:30+00:00","author":{"name":"Miguel Perales M.D.","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/miguel-angel-perales","image":"https:\/\/pbs.twimg.com\/profile_images\/420287281832787968\/QqvGIWhX_normal.jpeg","description":"Oncologist @sloan_kettering. Stem cell transplantation Lymphoma Leukemia MDS Myeloma Immunotherapy Vaccines. @BeTheMatch & @ASBMT Board Member. Tweets mine.","id_on_source":"DrMiguelPerales","tweeter_id":"1407780158","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":6676},"tweet_id":"912058432018108417"},{"url":"http:\/\/twitter.com\/frickjifang\/statuses\/912078278609051648","license":"gnip","rt":["DamianoRondell1"],"citation_ids":[24456548],"posted_on":"2017-09-24T22:16:21+00:00","author":{"name":"frickjifang","url":"http:\/\/frickjifang.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/299830865\/________004_normal.jpg","description":"PhD Student @ UIC; Graduate of UM-SPH, SSMU. Lifelong learner","id_on_source":"frickjifang","tweeter_id":"13002422","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":841},"tweet_id":"912078278609051648"},{"url":"http:\/\/twitter.com\/EBMT2017\/statuses\/912194191194836993","license":"gnip","rt":["DamianoRondell1"],"citation_ids":[24456548],"posted_on":"2017-09-25T05:56:57+00:00","author":{"name":"Thercell MRS","url":"http:\/\/www.institutpaolicalmettes.fr","image":"https:\/\/pbs.twimg.com\/profile_images\/861661859073667072\/okTi2D_S_normal.jpg","description":"Head & Qualified Person. Cell Collection & Cell Processing Facility. Comprehensive Cancer Center. Inserm CBT-1409. AMU, all in Marseille, France.","id_on_source":"EBMT2017","tweeter_id":"3361663613","geo":{"lt":46,"ln":2,"country":"FR"},"followers":11},"tweet_id":"912194191194836993"},{"url":"http:\/\/twitter.com\/jlll_hem\/statuses\/912196521696907264","license":"gnip","rt":["hidrhere"],"citation_ids":[24456548],"posted_on":"2017-09-25T06:06:13+00:00","author":{"name":"Jose Luis Lopez","image":"https:\/\/pbs.twimg.com\/profile_images\/765671185921310720\/lGg0XbLS_normal.jpg","description":"Me gusta mi trabajo y llevar la contraria. Hacer todo el bien posible es el objetivo. La sinceridad es un plus. El deporte ayuda a llevar mejor la vida.","id_on_source":"jlll_hem","tweeter_id":"735220184194125824","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":97},"tweet_id":"912196521696907264"}],"news":[{"title":"Transplantations May Have Similar Outcomes in Hodgkin's Lymphoma Regardless of Origin","url":"http:\/\/ct.moreover.com\/?a=31692186747&p=1pl&v=1&x=4lhmL4ihj_Rjissg41QqSw","license":"public","citation_ids":[24456548,24456548],"posted_on":"2017-08-31T17:00:00+00:00","summary":"August 31, 2017 Researchers evaluated the outcomes of patients with HL who received HAPLO, SIB, or MUD transplantations.","author":{"name":"Oncology Nurse Advisor ","url":"http:\/\/www.oncologynurseadvisor.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/276\/normal\/Screen_Shot_2014-11-20_at_11.19.42.png?1416482413"}},{"title":"Posttransplantation Cyclophosphamide-Based Haploidentical HCT in Hodgkin Lymphoma","url":"http:\/\/ct.moreover.com\/?a=31839794392&p=1pl&v=1&x=ybo1Xh7fNWKNxVL3YFD-0Q","license":"public","citation_ids":[24456548,24456548],"posted_on":"2017-09-14T22:05:26+00:00","summary":"By Matthew Stenger Posted: 9\/14\/2017 10:40:12 AM Last Updated: 9\/14\/2017 10:40:12 AM Tweet this page Advertisement Progression-free and overall survival with haploidentical allogeneic HCT was similar compared with HLA-matched sibling donor and HLA-mat\u2026","author":{"name":"The ASCO Post","url":"http:\/\/www.ascopost.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/496\/normal\/Screen_Shot_2016-02-03_at_09.24.05.png?1454491455"}}]}}